VSee Health (Nasdaq: VSEE) is a telehealth technology and services company delivering high-acuity virtual care solutions through its scalable, API-driven platform. VSEE offerings integrate secure video, device data, and EHR connectivity to power hospital systems, health networks, and employers.
VSEE technology powers healthcare networks and organizations worldwide, enabling seamless patient-provider interactions and ensuring efficient care delivery. Field-hardened on over 1.5M HIPAA-compliant video encounters every month, VSEE highly scalable, customizable telehealth building blocks each meet stringent security standards.
VSEE has deployed services in over 50 countries, including Iraq, Syria, Marshall Islands and El Salvador. Clients include NASA, US Department of Health and Human Services, McKesson, Magellan, DaVita, GE, countless startups, and the entire country of Qatar. VSEE also provides tailored solutions for critical shortage areas such as critical care and teleradiology. VSEE is committed to empowering high quality healthcare access and reducing physician burnout and workforce shortages through its telehealth technology
VSEE has a strategic partnership with AbundaBox to launch AbundaLife™, a groundbreakinghealth record management platform.This innovative solution addresses one of the most pressing challenges in healthcare—fragmented medical records—by consolidating personal health data into one secure, comprehensive profile.
VSEE also has an agreement wih Ava Robotics, a developer of intelligent robots for the workplace, to develop telepresence solutions for the inpatient intensive care market, including the development of a VSEE-powered Ava robot that allows providers to extend their reach and provide personalized care remotely.
Recent Strategic Sale for Refocus on Telehealth and Digital Health Solutions
On June 22nd VSEE provided an update on its business operations and financial success following its strategic sale of VSee Lab on May 31, 2026.
Pro-forma financials from enhanced focus on iDoc telehealth platform and enterprise healthcare solutions:
+60% revenue growth to $8 million in 2025.
+70% revenue growth to $2.5 million in Q1 2026.
Approximate reduction of $6.0 million in annual operating expenses.
Several large IDN (Integrated Health Network) multi-year contracts that were signed throughout 2025 are continuing to roll out, build revenue and add more telehealth services.
VSEE Chairman and Chief Executive Officer Dr. Imoigele Aisiku commented, “Nearly one month since our decision to separate out VSee Lab and we are already seeing improved operational and financial efficiencies. Our team is super driven to ramp and grow existing contracts and identify, prospect and close new contracts from our ever-expanding business pipeline. With our hospital network continuing to grow, margins continuing to improve and operating expenses continuing to be reduced, we believe can achieve $20 million revenue and profitability over the next 12 months is a realistic target.”
VSEE Completes Strategic Separation of VSee Lab, Retires Approximately 7% of Outstanding Shares, and Transitions to Single CEO Leadership
On June 11th VSEE announced the completion of a transformative strategic transaction that separates the Company from its former laboratory subsidiary, VSee Lab, eliminates a significant block of outstanding shares, and positions VSEE to focus exclusively on its core telehealth and digital health platform businesses.
Under a Stock Purchase Agreement dated May 31, 2026, VSEE sold 100% of VSee Lab, Inc. to former Co-Chief Executive Officer and Chairman Milton Chen. In connection with the transaction, Mr. Chen transferred all 2,870,069 shares of VSEE common stock owned by him back to the Company and assumed responsibility for the remaining liabilities of VSee Lab following closing. The returned shares represent approximately 7% of VSEE outstanding common stock and are expected to significantly improve shareholder alignment while simplifying the Company’s capital structure.
2025 Financial Results: Revenue Grows 40% Year-over-Year with Strong Year End Balance Sheet
On April 1st VSEE reported its financial and operational results for the full year ended December 31, 2025.
Key Financial Highlights (Year-over-Year Comparisons)
Revenue increased 40% to $14,618,184 in 2025 from $10,421,352 in 2024,
Gross margin rose 2% to $7,355,965 from $7,177,580,
Operating expenses declined sharply by 76%,
VSEE strengthened its balance sheet through multiple debt to equity conversions.
Cash and cash equivalents increased to $5,266,286 at December 31, 2025, from $326,115 at December 31, 2024
Key Business Highlights
During 2025 VSEE focused on reducing public expenses associated with the IPO, and growth in its telehealth clinical services group.
VSEE derived its 40% revenue growth by targeting large IDN’s (Integrated Health Networks) in the USA. The team signed several large scale multi-year contracts (one for $10 million per year previously announced) in early and mid 2025. The telehealth revenue for new large healthcare institutional accounts takes several months to begin, as the operations are complex and must be integrated into VSEE technology before rolling out services. This is particularly important for investors to understand that a majority of 2025 growth was in the second half of the year, and subsequently provides solid future growth in those accounts during 2026 as services continue to roll out to as many as 20 states this fiscal year.
VSEE continues to service government accounts such as NASA. In 2025 VSee Labs Inc was nominated and approved for Fedramp High status with the Federal Government as a technology partner. This was achieved through its HHS (Health and Human Services) contract awarded during 2024 and into 2025. VSEE continues to pursue several government healthcare related projects in 2026.
VSEE enters 2026 with a fully integrated digital-to-physical care platform, scalable AI telehealth infrastructure, and proven high-acuity clinical delivery. VSEE continues to target the rapidly growing hybrid care market while focusing on operational efficiencies, contract renewals, and new enterprise wins.
World’s First Autonomous Telehealth AI Robot
On March 10th VSEE announced the launch of the VSEE AI Robot at HIMSS 2026 in Las Vegas – the world’s first fully autonomous telehealth AI robot purpose-built for hospital and health system deployment. The VSEE AI Robot enables remote clinicians to navigate directly to a patient’s bedside without requiring onsite staff assistance, delivering true virtual rounding, rapid telestroke response, and specialist coverage across emergency departments and ICUs at scale.
For the first time, a single autonomous robot can replace or augment multiple manual workflows simultaneously – from remote physician rounding to medication and supplies delivery – while integrating seamlessly into existing clinical AI ecosystems through a VSEE proprietary AI Workflow Engine.
Unlike traditional telepresence carts that require staff to physically escort or reposition them, the VSEE AI Robot uses advanced LiDAR navigation to independently travel hospital corridors, enter patient rooms, and position itself at the bedside – day or night, with 30X optical and infrared night vision. Its surgical-grade display delivers high-definition virtual encounters while programmable drawers enable secure medication and supply delivery on the same autonomous pass.
The VSEE AI Robot is powered by the VSEE AI Workflow Engine, a no-code/low-code AI activation layer that enables hospitals to deploy and govern a library of clinical AI modules – from AI Copilot-assisted scheduling and coding to Early Warning vitals deterioration alerts and Stroke CT Hemorrhage notifications – without rebuilding existing IT infrastructure or enduring 12-month integration cycles.
The VSEE platform’s modular Building Blocks architecture means health systems can configure and scale in days, not months – with VSEE guaranteeing common customizations in as little as 1 day to 1 month.
Strategic Managed Services Partnership With GoMyRx, an Affiliate of GoMyDocs, to Accelerate Integrated Digital Healthcare Delivery
On February 5th VSEE announced a strategic managed services partnership with GoMyRx, a digital prescription fulfillment platform and affiliate company of the GoMyDocs healthcare ecosystem, designed to expand integrated digital healthcare delivery capabilities and support telehealth-enabled medication fulfillment nationwide.
GoMyRx currently operates a national prescription fulfillment platform supporting annual gross transaction volume exceeding $10 million, providing existing operational scale and infrastructure capacity to support the expanded partnership.
The integrated platform connects the VSEE telehealth infrastructure — including secure video visits, AI-assisted clinical workflows, remote patient monitoring, and EHR integrations — with GoMyRx’s fulfillment operations and GoMyDocs’ pharmaceutical compounding and logistics network.
For more information on $VSEE visit: www.vseehealth.com or https://www.idocvms.com
Media Contact: Company Name: VSee Health (Nasdaq: VSEE) Contact: Justin Smith Email: [email protected] Phone: 626-513-1824 Country: United States
DISCLAIMER: https://corporateads.com/disclaimer/
Disclosure listed on the CorporateAds website
Media ContactCompany Name: Vsee Health, Inc.Contact Person: Justin SmithEmail: Send EmailPhone: 626-513-1824Address:One Gateway Center Suite 507 300 Washington St. City: NewtonState: MassachusettsCountry: United StatesWebsite: www.vseehealth.com
